The Latest Breaking News from Masimo

Masimo stock rallies as Danaher announces plans of buying the health tech firm for $180 a share in cash. But is there any further upside left in MASI shares?

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.10%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.13%. March E-mini S&P futures (ESH26 ) rose +0.12%, and March E-mini Nasdaq futures...

Apple has been sued for $634 million in a patent dispute centered on the Apple Watch.

In over three decades, Joe Kiani led Masimo from a California startup into a global leader in patient monitoring. Since his resignation in late 2024, Kiani has not slowed down but rather redirected his energy into a series of ventures that combine health, technology, and human connection.

In a world where healthcare expenditures continue to skyrocket and chronic illnesses burden national economies, a quiet revolution is taking place in the medical technology space. One visionary leading this transformation is Joe Kiani, the entrepreneur behind Masimo and now the founder of Willow Laboratories.

“We think each brand has a special place, especially in the high-end market…”

Harman has completed its acquisition of the Sound United stable of brands from Masimo.

For Kiani, entrepreneurship has never been merely about building companies; it has been about solving pressing problems with persistence and vision.

Health company Masimo sues the US government for allowing the Apple Watch to regain its blood oxygen feature.